291 related articles for article (PubMed ID: 20427420)
21. Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis.
Algeciras-Schimnich A; Milosevic D; McIver B; Flynn H; Reddi HV; Eberhardt NL; Grebe SK
Clin Chem; 2010 Mar; 56(3):391-8. PubMed ID: 20056739
[TBL] [Abstract][Full Text] [Related]
22. Analysis of RAS mutation and PAX8/PPARγ rearrangements in follicular-derived thyroid neoplasms in a Korean population: frequency and ultrasound findings.
Jeong SH; Hong HS; Kwak JJ; Lee EH
J Endocrinol Invest; 2015 Aug; 38(8):849-57. PubMed ID: 25999051
[TBL] [Abstract][Full Text] [Related]
23. Detection of PAX8-PPARG fusion transcripts in archival thyroid carcinoma samples by conventional RT-PCR.
Klemke M; Drieschner N; Belge G; Burchardt K; Junker K; Bullerdiek J
Genes Chromosomes Cancer; 2012 Apr; 51(4):402-8. PubMed ID: 22179975
[TBL] [Abstract][Full Text] [Related]
24. RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics.
Leeman-Neill RJ; Brenner AV; Little MP; Bogdanova TI; Hatch M; Zurnadzy LY; Mabuchi K; Tronko MD; Nikiforov YE
Cancer; 2013 May; 119(10):1792-9. PubMed ID: 23436219
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathology of well-differentiated thyroid carcinomas.
Sobrinho-Simões M; Preto A; Rocha AS; Castro P; Máximo V; Fonseca E; Soares P
Virchows Arch; 2005 Nov; 447(5):787-93. PubMed ID: 16189702
[TBL] [Abstract][Full Text] [Related]
26. Is thyroid follicular cancer in Japanese caused by a specific t(2; 3)(q13; p25) translocation generating Pax8-PPAR gamma fusion mRNA?
Hibi Y; Nagaya T; Kambe F; Imai T; Funahashi H; Nakao A; Seo H
Endocr J; 2004 Jun; 51(3):361-6. PubMed ID: 15256783
[TBL] [Abstract][Full Text] [Related]
27. Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes.
Niepomniszcze H; Suárez H; Pitoia F; Pignatta A; Danilowicz K; Manavela M; Elsner B; Bruno OD
Thyroid; 2006 May; 16(5):497-503. PubMed ID: 16756473
[TBL] [Abstract][Full Text] [Related]
28. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.
Nikiforova MN; Biddinger PW; Caudill CM; Kroll TG; Nikiforov YE
Am J Surg Pathol; 2002 Aug; 26(8):1016-23. PubMed ID: 12170088
[TBL] [Abstract][Full Text] [Related]
29. [Oncogenes and thyroid tumors].
Lacroix L; Soria JC; Bidart JM; Schlumberger M
Bull Cancer; 2005 Jan; 92(1):37-43. PubMed ID: 15689324
[TBL] [Abstract][Full Text] [Related]
30. Decreased expression of thyrotropin receptor gene suggests a high-risk subgroup for oncocytic adenoma.
Mirebeau-Prunier D; Guyétant S; Rodien P; Franc B; Baris O; Rohmer V; Reynier P; Tourmen Y; Malthièry Y; Savagner F
Eur J Endocrinol; 2004 Mar; 150(3):269-76. PubMed ID: 15012610
[TBL] [Abstract][Full Text] [Related]
31. The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
Reddi HV; McIver B; Grebe SK; Eberhardt NL
Endocrinology; 2007 Mar; 148(3):932-5. PubMed ID: 16946003
[TBL] [Abstract][Full Text] [Related]
32. Underexpression of peroxisome proliferator-activated receptor (PPAR)gamma in PAX8/PPARgamma-negative thyroid tumours.
Marques AR; Espadinha C; Frias MJ; Roque L; Catarino AL; Sobrinho LG; Leite V
Br J Cancer; 2004 Aug; 91(4):732-8. PubMed ID: 15238980
[TBL] [Abstract][Full Text] [Related]
33. Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogene.
Lui WO; Foukakis T; Lidén J; Thoppe SR; Dwight T; Höög A; Zedenius J; Wallin G; Reimers M; Larsson C
Oncogene; 2005 Feb; 24(8):1467-76. PubMed ID: 15608688
[TBL] [Abstract][Full Text] [Related]
34. Fluorescence in situ hybridization analysis using PAX8- and PPARG-specific probes reveals the presence of PAX8-PPARG translocation and 3p25 aneusomy in follicular thyroid neoplasms.
Chia WK; Sharifah NA; Reena RM; Zubaidah Z; Clarence-Ko CH; Rohaizak M; Naqiyah I; Srijit D; Hisham AN; Asmiati A; Rafie MK
Cancer Genet Cytogenet; 2010 Jan; 196(1):7-13. PubMed ID: 19963130
[TBL] [Abstract][Full Text] [Related]
35. [Transfection of follicular thyroid gland carcinoma cells with human TSH receptor changes growth, invasion and adhesion].
Hoelting T; Duh QY; Clark OH; Herfarth C
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):281-4. PubMed ID: 14518260
[TBL] [Abstract][Full Text] [Related]
36. Thyroid follicle formation and thyroglobulin expression in multipotent endodermal stem cells.
Ma R; Latif R; Davies TF
Thyroid; 2013 Apr; 23(4):385-91. PubMed ID: 23360087
[TBL] [Abstract][Full Text] [Related]
37. Association between Pax8-PPARandgamma;1 Rearrangement and Follicular Thyroid Cancer: a Meta-Analysis.
Li HY; Xie ZH; Xu CH; Pu ML; Chen ZY; Yu M; Wang HS; Zhou CM; Pu CY; Liu W
Asian Pac J Cancer Prev; 2016; 17(9):4247-4250. PubMed ID: 27797226
[TBL] [Abstract][Full Text] [Related]
38. Dissecting molecular events in thyroid neoplasia provides evidence for distinct evolution of follicular thyroid adenoma and carcinoma.
Krause K; Prawitt S; Eszlinger M; Ihling C; Sinz A; Schierle K; Gimm O; Dralle H; Steinert F; Sheu SY; Schmid KW; Fuhrer D
Am J Pathol; 2011 Dec; 179(6):3066-74. PubMed ID: 21983636
[TBL] [Abstract][Full Text] [Related]
39. Intragenic mutations in thyroid cancer.
Sobrinho-Simões M; Máximo V; Rocha AS; Trovisco V; Castro P; Preto A; Lima J; Soares P
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):333-62, viii. PubMed ID: 18502330
[TBL] [Abstract][Full Text] [Related]
40. Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines.
Park JW; Zarnegar R; Kanauchi H; Wong MG; Hyun WC; Ginzinger DG; Lobo M; Cotter P; Duh QY; Clark OH
Thyroid; 2005 Mar; 15(3):222-31. PubMed ID: 15785241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
